supp.fit

Asafoetida

9 benefits mapped to clinical evidence across supplements.

Benefit Evidence

Oxidative stress ↓

BMI ↓

64 people

Oxidative stress ↓

BMI ↓

64 people

BMI ↓

Oxidative stress ↓

Sexual function ↑

64 people

Gut microbiome shift -72%

Dyspepsia relief -81%

Attention gain -44%

56 people

Reduced early satiety βˆ’81%

Less fullness/bloating βˆ’53% to βˆ’60%

56 people

Bloating βˆ’60%, gas βˆ’33%

Gut shift, less bloating

56 people

Dyspepsia relief: βˆ’81%

Microbiome shift: βˆ’72%

56 people

Less bloating, better sleep

F/B ratio βˆ’72%, RT βˆ’44%

56 people

Dyspepsia symptoms -81%

Gut balance -72%

56 people

Research sources

Antioxidant (1)
  1. Evaluation of the Potential Beneficial Effects of Ferula communis L. Extract Supplementation in Postmenopausal Discomfort

    PubMed ID: 39203788

    90‑day RCT (Ferula communis) showed decreased plasma free radicals (d‑ROMs); related Ferula species so evidence is reasonably strong but indirect to asafoetida.

Inflammation (1)
  1. Evaluation of the Potential Beneficial Effects of Ferula communis L. Extract Supplementation in Postmenopausal Discomfort

    PubMed ID: 39203788

    Decreased plasma free radicals in a Ferula communis RCT suggests reduced oxidative/inflammatory burden (indirect to asafoetida).

Metabolism (1)
  1. Evaluation of the Potential Beneficial Effects of Ferula communis L. Extract Supplementation in Postmenopausal Discomfort

    PubMed ID: 39203788

    Ferula communis RCT produced a modest BMI reduction over 90 days, suggesting a metabolic effect (species differs from asafoetida).

Antimicrobial (1)
  1. Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study

    PubMed ID: 41054174

    Asafin shifted gut microbiome (F/B ratio fell ~72%), indicating microbiome‑modulating or selective antimicrobial effects in the gut.

Appetite stimulation (1)
  1. Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study

    PubMed ID: 41054174

    Asafin reduced early satiety (βˆ’81%), which would be expected to increase appetite/meal tolerance.

Bloating & gas (1)
  1. Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study

    PubMed ID: 41054174

    Asafoetida (Asafin) 14‑day RCT: bloating reduced β‰ˆ60% vs placebo β€” direct, large clinical effect.

Digestive support (1)
  1. Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study

    PubMed ID: 41054174

    Asafin RCT produced broad, significant improvements in dyspepsia symptoms (early satiety, fullness, bloating, heartburn, belching).

Relaxation (1)
  1. Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study

    PubMed ID: 41054174

    Asafin RCT improved sleep scores (BIS) and attention measures over 14 days, consistent with relaxation/sleep benefits.

Stomach comfort (1)
  1. Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study

    PubMed ID: 41054174

    Asafoetida RCT showed rapid, large reductions in multiple dyspepsia symptoms (direct evidence of soothing stomach/discomfort).

Similar by evidence

Supplements the same benefits carry qualifying findings for β€” a fact about the evidence graph, not a recommendation to swap.

Products with Asafoetida

Search all

20 products whose verified label declares Asafoetida β€” not every bottle that mentions it in a title.